Market Cap 54.59M
Revenue (ttm) 0.00
Net Income (ttm) -7.81M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin 0.00%
Debt to Equity Ratio 0.38
Volume 150,400
Avg Vol 201,602
Day's Range N/A - N/A
Shares Out 14.07M
Stochastic %K 67%
Beta 2.08
Analysts Strong Buy
Price Target N/A

Latest News on ALTS

ALT5 Sigma to Exhibit at Transact Las Vegas April 2-4, 2025

Mar 26, 2025, 9:00 AM EDT - 7 days ago

ALT5 Sigma to Exhibit at Transact Las Vegas April 2-4, 2025


ALT5 Sigma to Exhibit at iFX EXPO Dubai January 14-16, 2025

Jan 9, 2025, 11:30 AM EST - 2 months ago

ALT5 Sigma to Exhibit at iFX EXPO Dubai January 14-16, 2025


ALT5 Sigma Announces Results of 2024 AGM and Corporate Update

Dec 18, 2024, 4:00 PM EST - 3 months ago

ALT5 Sigma Announces Results of 2024 AGM and Corporate Update


ALT5 Sigma to Exhibit at Money20/20 October 27-30, 2024

Oct 23, 2024, 5:00 PM EDT - 5 months ago

ALT5 Sigma to Exhibit at Money20/20 October 27-30, 2024


ALT5 Sigma to Exhibit at iFX Bangkok September 16-18, 2024

Sep 9, 2024, 8:00 AM EDT - 7 months ago

ALT5 Sigma to Exhibit at iFX Bangkok September 16-18, 2024


ALT 5 Sigma to Exhibit at SiGMA Budapest September 2-4, 2024

Aug 23, 2024, 11:00 AM EDT - 7 months ago

ALT 5 Sigma to Exhibit at SiGMA Budapest September 2-4, 2024


JanOne Inc. added to the Russell Microcap® Index

Jun 3, 2024, 12:05 PM EDT - 10 months ago

JanOne Inc. added to the Russell Microcap® Index


JanOne Regains Compliance with Nasdaq's Listing Requirements

Mar 15, 2024, 9:00 AM EDT - 1 year ago

JanOne Regains Compliance with Nasdaq's Listing Requirements


JanOne Completes Pre-IND Meeting with FDA on Jan123

Apr 18, 2023, 8:30 AM EDT - 2 years ago

JanOne Completes Pre-IND Meeting with FDA on Jan123